Co-cultivation is a powerful approach to produce a robust functionally designed synthetic consortium as a live biotherapeutic product (LBP)

The success of fecal microbiota transplants (FMT) has provided the necessary proof-of-concept for microbiome therapeutics. Yet, feces-based therapies have many associated risks and uncertainties, and hence defined microbial consortia that modify the microbiome in a targeted manner have emerged as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurt, Fabienne, Leventhal, Gabriel E., Spalinger, Marianne Rebecca, Anthamatten, Laura, Rogalla von Bieberstein, Philipp, Menzi, Carmen, Reichlin, Markus, Meola, Marco, Rosenthal, Florian, Rogler, Gerhard, Lacroix, Christophe, de Wouters, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980632/
https://www.ncbi.nlm.nih.gov/pubmed/36794804
http://dx.doi.org/10.1080/19490976.2023.2177486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980632/
https://www.ncbi.nlm.nih.gov/pubmed/36794804
http://dx.doi.org/10.1080/19490976.2023.2177486

Ejemplares similares